| Phase 03 trials |
|
Phase 0
|
NCT05105087 |
Apr 2022 → Nov 2023 |
cervical carcinoma, vaginal carcinoma, vulvar carcinoma |
Thomas Jefferson University |
Completed
|
No outcome recorded
|
|
Phase 0
|
NCT03578224 |
Sep 2018 → Aug 2022 |
esophageal disorder |
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University |
Completed
|
No outcome recorded
|
|
Phase 0
|
NCT03009266 |
Jul 2018 → Dec 2019 |
myocardial ischemia |
Oregon Health and Science University |
Unknown
|
No outcome recorded
|
| Phase 13 trials |
|
Phase 1
|
NCT02968680 |
Apr 2017 → Jun 2019 |
cutaneous melanoma |
University of Southern California |
Terminated
|
No outcome recorded
|
|
Phase 1
|
NCT03340870 |
Oct → Nov 2014 |
— |
GE Healthcare |
Completed
|
No outcome recorded
|
|
Phase 1
|
NCT00156780 |
Aug 2004 → Jul 2005 |
chronic obstructive pulmonary disease, congestive heart failure |
Acusphere |
Completed
|
No outcome recorded
|
| Phase 1/21 trial |
|
Phase 1/2
|
NCT02652923 |
Jan 2016 → Jan 2022 |
breast cancer |
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University |
Completed
|
No outcome recorded
|
| Phase 23 trials |
|
Phase 2
|
NCT02733029 |
May 2018 → May 2022 |
transplant rejection |
Brigham and Women's Hospital |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT03245255 |
Dec 2017 → Sep 2020 |
heart failure |
Thomas Jefferson University |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT02398266 |
Aug 2016 → Jul 2018 |
peripheral arterial disease |
Oregon Health and Science University |
Unknown
|
No outcome recorded
|
| Phase 2/31 trial |
|
Phase 2/3
|
NCT07310758 |
Sep 2025 → Sep 2026 expected |
breast cancer, head and neck cancer, melanoma |
The Netherlands Cancer Institute |
Recruiting
|
No outcome recorded
|
| Phase 35 trials |
|
Phase 3
|
NCT05470205 |
Nov 2022 → Feb 2026 overdue |
portal hypertension |
Thomas Jefferson University |
Recruiting
|
No outcome recorded
|
|
Phase 3
|
NCT04006275 |
Jun → Dec 2019 |
cirrhosis of liver, hepatocellular carcinoma |
Second Affiliated Hospital, School of Medicine, Zhejiang University |
Unknown
|
No outcome recorded
|
|
Phase 3
|
NCT02651090 |
Oct 2017 → Mar 2018 |
— |
Northeastern Ohio Radiology Research and Education Fund |
Withdrawn
|
No outcome recorded
|
|
Phase 3
|
NCT03335566 |
May 2014 → Apr 2015 |
liver disorder |
GE Healthcare |
Completed
|
No outcome recorded
|
|
Phase 3
|
NCT00669851 |
Nov 2006 → Mar 2007 |
coronary artery disorder |
Acusphere |
Completed
|
No outcome recorded
|
| Phase 41 trial |
|
Phase 4
|
NCT02489045 |
Apr 2015 → Mar 2019 |
portal hypertension |
Thomas Jefferson University |
Completed
|
No outcome recorded
|
| Phase not applicable2 trials |
| — |
NCT05068076 |
Oct → Dec 2021 |
hepatocellular carcinoma |
Institute of Liver and Biliary Sciences, India |
Completed
|
No outcome recorded
|
| — |
NCT02737865 |
May 2016 → Apr 2019 |
focal nodular hyperplasia |
Samsung Medical Center |
Completed
|
No outcome recorded
|